The global “Vasopressin For Vasoplegic Shock Market”, size is expected to gain momentum by reaching USD 2,657.9 million by 2027, while exhibiting a stellar CAGR of 14.8% between 2020 and 2027. This is attributable to the increasing prevalence of cardiovascular surgeries that propels the demand for vasopressin for vasoplegic shock across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Vasopressin for Vasoplegic Shock Market Size, Share & COVID-19 Impact Analysis, By Application (Sepsis, Post Cardiac Surgery, and Others) Regional Forecast, 2020-2027.” The report further mentions that the market stood at USD 890.9 million in 2019.
Request a Sample Copy of the Research Report:
Rising Cardiac Syndrome Cases amid COVID-19 to Boost Growth
The recent spike in the cases of people suffering from the novel coronavirus disease is expected to surge the cardiac syndrome risk amongst people susceptible to contracting it. This is leading the pharmaceutical sector to focus on developing advanced vasopressin drugs for treatment purposes. This is expected to bode well for the growth of the global market in the near future.
Vasoplegia is a type of syndrome that involves pathologically low systemic vascular resistance. It further leads to reduced blood pressure amid presence of a raised cardiac output. The growing adoption of vasopressin for vasoplegic shock treatment is gaining popularity owing to its efficiency in treating the syndrome.
DRIVING FACTORS
Increasing Incidence of Cardiovascular Surgeries to Augment Growth
According to the Centers for Disease Control and Prevention (CDC), every year about 340,000 Coronary Artery Bypass Grafting (CABG) procedures are performed in the U.S. The increasing number of cardiovascular surgeries propels the demand for vasopressin to control the blood flow. Additionally, the growing number of CABG procedures and sepsis patients are boosting the demand for innovative vasopressin treatment options. This is expected to bode well for the global vasopressin for vasoplegic shock market growth during the forecast period.
SEGMENTATION
Post Cardiac Surgery Segment Held 25.2% in 2019
The post cardiac segment, based on application, held a market share of about 25.2% in 2019 and is likely to gain momentum owing to the increasing number of cardiac surgeries that require efficient post-cardiac treatment globally.
Quick Buy – Vasopressin for Vasoplegic Shock Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/104065
REGIONAL INSIGHTS
Increasing Prevalence of Sepsis in North America to Favor Growth
Among all the regions, North America stood at USD 561.3 million in 2019 and is expected to hold the highest position in the global market in the forthcoming years. This is ascribable to the increasing prevalence of sepsis that drives the demand for advanced vasopressin for vasoplegic shock treatment procedures in the region.
The market in Europe is expected to experience a significant growth backed by surging investments in R&D by the government as well as major companies to develop advanced vasopressin for vasoplegic shock treatment between 2020 and 2027.
COMPETITIVE LANDSCAPE
Prominent Companies Focus on Investment in R&D Activities to Develop Innovative Vasopressin for Vasoplegic Shock
The global vasopressin for vasoplegic shock market is fragmented by the presence of key players that are focusing on raising investments to develop advanced vasopressin for vasoplegic shock treatment. Additionally, the major companies are striving to maintain their presence in the global marketplace by adopting strategies such as partnership, collaboration, and merger and acquisition to gain a competitive edge over their rivals during the forecast period.
Industry Development:
- April 2018 – Eagle Pharmaceuticals, Inc announced the approval of its new drug application, ANDA for 1ml vasopressin injection. The product is a original generic version of Endo International plc’s Vasostrict formulation.
List of the Companies Profiled in the Market:
- Endo International plc (Dublin, Ireland)
- AMOMED Pharma (Vienna, Austria)
- La Jolla Pharmaceutical Company (California, U.S.)
- Pfizer Inc. (New York, U.S.)
- Ferring Pharmaceuticals (Saint-Prex, Switzerland)
- Fresenius Kabi Canada (Toronto, Canada)
- Astellas Pharma (Tokyo, Japan)
- Eagle Pharmaceuticals, Inc. (New Jersey, U.S.)
- Others
Have Any Query? Ask Our Experts:
Global Vasopressin for Vasoplegic Shock Market Segmentation :
By Application
- Sepsis
- Post Cardiac Surgery
- Others
By Geography
- North America
- By Application
- By Country
- Europe
- By Application
- By Country/Sub-region
- Asia Pacific
- By Application
- By Country/Sub-region
- Latin America
- By Application
- By Country/Sub-region
- The Middle East & Africa
- By Application
- By Country/Sub-region
Table of Content:
1 Vasopressin for Vasoplegic Shock Market Overview
1.1 Vasopressin for Vasoplegic Shock Product Overview
1.2 Vasopressin for Vasoplegic Shock Market Segment by Type
1.3 Global Vasopressin for Vasoplegic Shock Market Size by Type (2015-2027)
1.3.1 Global Vasopressin for Vasoplegic Shock Market Size Overview by Type (2015-2027)
1.3.2 Global Vasopressin for Vasoplegic Shock Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Vasopressin for Vasoplegic Shock Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Vasopressin for Vasoplegic Shock Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Vasopressin for Vasoplegic Shock Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Vasopressin for Vasoplegic Shock Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Vasopressin for Vasoplegic Shock Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Vasopressin for Vasoplegic Shock Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Vasopressin for Vasoplegic Shock Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Vasopressin for Vasoplegic Shock Sales Breakdown by Type (2015-2027)
1.4.2 Europe Vasopressin for Vasoplegic Shock Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Vasopressin for Vasoplegic Shock Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Vasopressin for Vasoplegic Shock Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Vasopressin for Vasoplegic Shock Sales Breakdown by Type (2015-2027)
2 Global Vasopressin for Vasoplegic Shock Market Competition by Company
2.1 Global Top Players by Vasopressin for Vasoplegic Shock Sales (2015-2021)
2.2 Global Top Players by Vasopressin for Vasoplegic Shock Revenue (2015-2021)
2.3 Global Top Players Vasopressin for Vasoplegic Shock Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Vasopressin for Vasoplegic Shock Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vasopressin for Vasoplegic Shock Market Competitive Situation and Trends
2.5.1 Vasopressin for Vasoplegic Shock Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Vasopressin for Vasoplegic Shock Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasopressin for Vasoplegic Shock as of 2019)
2.7 Date of Key Company Enter into Vasopressin for Vasoplegic Shock Market
2.8 Key Company Vasopressin for Vasoplegic Shock Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Vasopressin for Vasoplegic Shock Status and Outlook by Region (2015-2027)
3.1 Global Vasopressin for Vasoplegic Shock Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Vasopressin for Vasoplegic Shock Market Size Market Share by Region (2015-2021)
3.2.1 Global Vasopressin for Vasoplegic Shock Sales Market Share by Region (2015-2021)
3.2.2 Global Vasopressin for Vasoplegic Shock Revenue Market Share by Region (2015-2021)
3.2.3 Global Vasopressin for Vasoplegic Shock Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Vasopressin for Vasoplegic Shock Market Size Market Share by Region (2021-2027)
3.3.1 Global Vasopressin for Vasoplegic Shock Sales Market Share by Region (2021-2027)
3.3.2 Global Vasopressin for Vasoplegic Shock Revenue Market Share by Region (2021-2027)
3.3.3 Global Vasopressin for Vasoplegic Shock Sales, Revenue, Price and Gross Margin (2021-2027)
3.4 North America Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
3.4.1 North America Vasopressin for Vasoplegic Shock Revenue By Growth (2015-2027)
3.4.2 North America Vasopressin for Vasoplegic Shock Sales By Growth (2015-2027)
3.5 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
3.5.1 Asia-Pacific Vasopressin for Vasoplegic Shock Revenue By Growth (2015-2027)
3.5.2 Asia-Pacific Vasopressin for Vasoplegic Shock Sales By Growth (2015-2027)
3.6 Europe Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
3.6.1 Europe Vasopressin for Vasoplegic Shock Revenue By Growth (2015-2027)
3.6.2 Europe Vasopressin for Vasoplegic Shock Sales By Growth (2015-2027)
3.7 Latin America Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
3.7.1 Latin America Vasopressin for Vasoplegic Shock Revenue By Growth (2015-2027)
3.7.2 Latin America Vasopressin for Vasoplegic Shock Sales By Growth (2015-2027)
3.8 Middle East and Africa Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
3.8.1 Middle East and Africa Vasopressin for Vasoplegic Shock Revenue By Growth (2015-2027)
3.8.2 Middle East and Africa Vasopressin for Vasoplegic Shock Sales By Growth (2015-2027)
4 Global Vasopressin for Vasoplegic Shock by Application
4.1 Vasopressin for Vasoplegic Shock Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Vasopressin for Vasoplegic Shock Sales by Application: 2015 VS 2021 VS 2027
4.3 Global Vasopressin for Vasoplegic Shock Historic Sales by Application (2015-2021)
4.4 Global Vasopressin for Vasoplegic Shock Forecasted Sales by Application (2021-2027)
4.5 Key Regions Vasopressin for Vasoplegic Shock Market Size by Application
4.5.1 North America Vasopressin for Vasoplegic Shock by Application
4.5.2 Europe Vasopressin for Vasoplegic Shock by Application
4.5.3 Asia-Pacific Vasopressin for Vasoplegic Shock by Application
4.5.4 Latin America Vasopressin for Vasoplegic Shock by Application
4.5.5 Middle East and Africa Vasopressin for Vasoplegic Shock by Application
5 North America Vasopressin for Vasoplegic Shock Market Size by Country (2015-2027)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Vasopressin for Vasoplegic Shock Sales Market Share by Country (2015-2021)
5.1.2 North America Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2027)
5.2.1 North America Vasopressin for Vasoplegic Shock Sales Market Share by Country (2021-2027)
5.2.2 North America Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2021-2027)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
5.3.2 Canada Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
6 Europe Vasopressin for Vasoplegic Shock Market Size by Country (2015-2027)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Vasopressin for Vasoplegic Shock Sales Market Share by Country (2015-2021)
6.1.2 Europe Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2027)
6.2.1 Europe Vasopressin for Vasoplegic Shock Sales Market Share by Country (2021-2027)
6.2.2 Europe Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2021-2027)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
6.3.2 France Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
6.3.3 U.K. Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
6.3.4 Italy Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
6.3.5 Russia Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Country (2015-2027)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)
7.1.1 Asia-Pacific Vasopressin for Vasoplegic Shock Sales Market Share by Country (2015-2021)
7.1.2 Asia-Pacific Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2015-2021)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)
7.2.1 Asia-Pacific Vasopressin for Vasoplegic Shock Sales Market Share by Country (2021-2027)
7.2.2 Asia-Pacific Vasopressin for Vasoplegic Shock Revenue Market Share by Country (2021-2027)
7.3 Asia-Pacific Market Size By Growth by Country
7.3.1 China Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.2 Japan Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.3 South Korea Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.4 India Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.5 Australia Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.6 Taiwan Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.7 Indonesia Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.8 Thailand Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.9 Malaysia Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
7.3.10 Philippines Vasopressin for Vasoplegic Shock Market Size By Growth (2015-2027)
Toc Continue…
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd